This information is based entirely on journal literature.Medtronic was made aware of this event through a search of literature publications.This event occurred outside the us.Patient information is limited due to confidentiality concerns.Of note, multiple patients and multiple manufacturers were noted in the article; however, a one-to-one correlation could not be made with unique product serial/lot numbers.The baseline gender/age characteristics is male/63 years old.Without a lot number or device serial number, the manufacturing date cannot be determined.Since no device id was provided, it is unknown if this event has been previously reported.Referenced article: systematic workflow and electrogram guidance to reduce x-ray exposure time during cryoballoon ablation of atrial fibrillation: the sweet-cryo strategy.Europace.2023; 25, 1¿13.Doi: 10.1093/europace/euad231.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
Literature was reviewed regarding cryoballoon pulmonary vein isolation.The authors described patients who experienced stroke or transient ischemic attack (tia), minor bleeding at the puncture site, and transient phrenic nerve palsy during the ablation procedure.The status of the catheters and sheaths is unknown.No additional adverse patient effects were reported.
|